Free Trial

Great Valley Advisor Group Inc. Buys 7,751 Shares of The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Great Valley Advisor Group Inc. lifted its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 10.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 78,834 shares of the company's stock after acquiring an additional 7,751 shares during the quarter. Great Valley Advisor Group Inc.'s holdings in Procter & Gamble were worth $13,654,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Acorn Creek Capital LLC grew its stake in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock worth $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its stake in shares of Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock worth $963,000 after acquiring an additional 59 shares in the last quarter. Hudson Value Partners LLC lifted its position in Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company's stock valued at $250,000 after acquiring an additional 60 shares during the period. Traveka Wealth LLC boosted its stake in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock worth $616,000 after acquiring an additional 60 shares in the last quarter. Finally, Fiduciary Alliance LLC grew its holdings in Procter & Gamble by 2.8% in the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company's stock worth $371,000 after purchasing an additional 61 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.

Insider Activity at Procter & Gamble

In related news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company's stock, valued at approximately $6,325,360. This represents a 25.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon R. Moeller sold 87,979 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.40, for a total value of $14,991,621.60. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $51,252,400.80. The trade was a 22.63 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 160,693 shares of company stock valued at $27,311,345. 0.18% of the stock is owned by company insiders.

Procter & Gamble Stock Performance

Procter & Gamble stock traded up $3.53 during midday trading on Friday, hitting $176.28. The stock had a trading volume of 10,609,785 shares, compared to its average volume of 6,613,133. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company has a market capitalization of $415.15 billion, a PE ratio of 30.39, a P/E/G ratio of 3.74 and a beta of 0.42. The firm's fifty day moving average is $170.04 and its two-hundred day moving average is $168.64.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company's revenue was down .6% on a year-over-year basis. During the same period last year, the firm earned $1.83 EPS. On average, research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio is currently 69.48%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on PG. Wolfe Research raised Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. DZ Bank upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price objective for the company in a report on Thursday, August 29th. JPMorgan Chase & Co. increased their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research note on Thursday, September 19th. Evercore ISI lifted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a report on Monday, October 21st. Finally, Dbs Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $178.00.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines